Cancer Gene Therapy

Special 01 February 2018

Special Issue on Genetically Modified T-Cells

We are pleased to share with you a special issue published in 2015 focused on Genetically Modified T-Cells. We hope you enjoy reading it.

Content

Genetically engineered lymphocytes and adoptive cell therapy: cancer immunotherapy’s smart bombs
- S K Libutti
Editorial10 Mar 2015 Cancer Gene Therapy
Moving from tinkering in the garage to assembly line production: the manufacture of genetically modified T cells expressing chimeric antigen receptors (CARs) comes on line
- L J N Cooper
Review13 Feb 2015 Cancer Gene Therapy
Manufacturing genetically modified T cells for clinical trials
- A P Gee
Review30 Jan 2015 Cancer Gene Therapy
Towards a commercial process for the manufacture of genetically modified T cells for therapy
- A D Kaiser
- M Assenmacher
- B Dropulic
ReviewOpen Access23 Jan 2015 Cancer Gene Therapy
Performance-enhancing drugs: design and production of redirected chimeric antigen receptor (CAR) T cells
- B L Levine
Review13 Feb 2015 Cancer Gene Therapy
Manufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapies
- X Wang
- I Rivière
Review27 Feb 2015 Cancer Gene Therapy
Manufacture of T cells using the Sleeping Beauty system to enforce expression of a CD19-specific chimeric antigen receptor
- H Singh
- J S E Moyes
- L J N Cooper
Review16 Jan 2015 Cancer Gene Therapy

Search

Advanced search

Quick links